Investigative Site

Portland, Oregon 97239

1 studies enrolling now · 9 studies all time

What they study most

AIS, Alopecia Areata, Constipation, Heavy Menstrual Bleeding, Irritable Bowel Syndrome With Diarrhea (IBS-D), Menorrhagia, Overactive Bladder (OAB), Pancreatic Cancer, Tumor Hyperinsulinism (Tumor HI)

Studies at this site

• A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism — Recruiting now
• Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients — Completed
• Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata — Completed
• NBP in Adult Patients With Acute Ischemic Stroke (AIS) — Completed
• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) — Completed
• Efficacy and Safety of XP12B in Women With Menorrhagia — Completed
• Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain — Stopped early
• Efficacy and Safety Study of XP12B in Women With Menorrhagia — Completed
• Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder — Completed